Company Filing History:
Years Active: 2005
Title: The Innovative Journey of Raymond Shapira
Introduction
Raymond Shapira, an inventive mind based in Atlanta, GA, has made significant contributions to the field of biomarker research. His notable work focuses on the detection and quantification of oxidative stress in proteins, an area that holds great promise for advancing medical diagnostics and therapeutic interventions.
Latest Patents
Raymond Shapira holds a patent for his groundbreaking invention titled "Biomarkers for Oxidative Stress." This patent pertains to methods of identifying and measuring oxidative stress biomarkers within proteins. The primary biomarker involved is any amino acid that has undergone oxidation or other modifications such as chloro-tyrosine and dityrosine. Notably, the invention emphasizes oxidized sulfur- or selenium-containing amino acids. Shapira's work includes the utilization of antibodies, either monoclonal or polyclonal, that specifically bind to these oxidized amino acids. The detection of these biomarkers can significantly aid in assessing the effectiveness of various environmental, nutritional, and therapeutic interventions.
Career Highlights
Throughout his career, Raymond Shapira has been affiliated with Emory University, where he contributes to pioneering research in biomarker detection. His work has not only expanded the understanding of oxidative stress but has also paved the way for innovative solutions in health monitoring and clinical diagnostics.
Collaborations
Raymond works alongside esteemed colleagues, including Joseph M. Kinkade, Jr. and Peter E. Jensen. Their collaborative efforts have enhanced research capabilities and fostered a stimulating academic environment at Emory University.
Conclusion
Raymond Shapira's contributions to his field, particularly through his patent on biomarkers for oxidative stress, reflect his dedication to scientific innovation. His work continues to impact the medical community, providing vital tools for research and the potential to improve patient health outcomes. As the landscape of biomarker analysis evolves, Shapira's inventions will remain at the forefront of this critical field.